Hong Kong ChaoShang Group Limited (SEHK:2322) entered into a memorandum of understanding to acquire Shenzhen City Lianhao Health and Chronic Disease Management Co. Ltd from Zheng Jinqiang and Huang Minfen on May 5, 2023. The Company may conduct due diligence including business, financial and legal due diligence on the Target Group for six months from the date of the memorandum of understanding.